ZURICH, Switzerland -- Prionics AG will be promoting the use of the innovative diagnostic ear tag TypiFix(TM), which combines individual livestock identification with tissue sampling in the fight against animal diseases that threaten human health.



"The special mummification technique of TypiFix(TM) allows it to easily trace back from the fork to the farm", says Gottfried Brem, inventor of TypiFix(TM). With a TypiFix(TM) sample, it is possible to perform various diagnostic tests, such as detecting viral diseases.



Another application for the innovative system is in animal breeding. If a farmer identifies animals with genetic defects early, they can be excluded from breeding. "There are various potential applications for TypiFix(TM). This makes the system so attractive. The product fills an important gap in consumer protection by combining traceability and diagnostics", says Bruno Oesch, chairman of Prionics. TypiFix(TM) has proven successful in different pilot studies with governments in Europe and livestock producers in the USA. Prionics believes that this diagnostic ear tag will establish itself as an international standard.



Prionics sells and distributes TypiFix(TM) over IDnostics AG, a separate business unit, established primarily to market this product. Prionics holds a majority-interest in IDnostics.



The award-winning TypiFix(TM) diagnostic ear tag extracts a tissue sample just when identifying the animal with the ear tag. The ear tissue is conserved at extraction and the farmer can send it to the laboratory for analysis easily and cost effectively by mail. The particular mummification technique ensures that a TypiFix(TM) sample can be stored at room temperature for years. The sample is suited for diagnostic tests as well as for DNA analysis. The extraction of a tissue sample, which contains an animal's DNA, makes the system tamper-proof.



Prionics, a world market leader for rapid mad-cow testing, was founded in 1997 as a spin-off from the University of Zurich. Prionics carries out research and development in diagnostics for prion diseases (such as BSE) and other zoonotic diseases.



SOURCE: Prionics AG via PR Newswire.